Services
- Biorepository Solutions
- ULT Transport
- Unlicensed Medicines
- Patient Support Program
- Managed Access Program
- Post-Trial Access
- Early Access Program
- Clinical Trial Comparator Sourcing
- Clinical And Commercial Secondary Packaging And Labeling
- Clinical Trials Logistics
- Clinical Trial Material Storage and Distribution
- Global Logistics for Life Sciences
- Pharmaceutical Wholesale Distribution
- Specialty Medicines
- Regulatory Affairs Support
Post-Trial Access: Extending Care Beyond Clinical Trials!
Post-Trial Access (PTA) refers to the provision of a product, either investigational treatment or comparator, to clinical trial participants following trial completion.
At Globyz, we understand the importance of continuity of care. Our Post-Trial Access programs ensure that patients continue to receive necessary treatments even after the clinical trial has ended.
With a commitment to patient well-being, we facilitate the seamless transition from trial phase to ongoing treatment, ensuring that there are no gaps in patient care.
Choose Globyz for reliable and compassionate Post-Trial Access solutions. Contact us today to learn more about how we can help you extend care beyond clinical trials and improve patient outcomes globally.